Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY)

22 August 2026

Docusign: The Market Hasn’t Caught Up To The Multiple Yet (NASDAQ:DOCU)

22 August 2026

DICK’S Sporting Goods Stock Is Hanging On By A Thread But Looks Like A Buy Ahead Of Q2

22 August 2026

Gen Digital: A Cheap Stock With An Underappreciated Growth Opportunity (NASDAQ:GEN)

22 August 2026

Lyntris: Defense Play Does Not Appear To Be A Defensive Investment (Pending:LYNX)

22 August 2026
Facebook X (Twitter) Instagram
Business Saturday, Aug 22
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY)
News

Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk22 August 20261 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

JR Research is an opportunistic investor. I was recognized by TipRanks as a Top Analyst, and also by Seeking Alpha as a “Top Analyst To Follow” for Technology, Software, and Internet, as well as for Growth and GARP. I identify attractive risk/reward opportunities supported by robust price action to potentially generate alpha well above the S&P 500. My picks have consistently demonstrated market outperformance over time. My approach combines timely and sharp price action analysis with fundamentals as my foundation. I also tend to avoid overhyped and overvalued stocks while capitalizing on battered stocks with significant upside recovery possibilities. I run the investing group Ultimate Growth Investing which specializes in identifying high-potential opportunities across various sectors. My main ideas revolve around stocks with strong growth potential, and also well-beaten contrarian plays. I designed the group for investors seeking to capitalize on growth stocks with solid fundamentals, robust buying momentum, and appealing turnaround plays to generate alpha consistently. Learn more

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Docusign: The Market Hasn’t Caught Up To The Multiple Yet (NASDAQ:DOCU)

DICK’S Sporting Goods Stock Is Hanging On By A Thread But Looks Like A Buy Ahead Of Q2

Gen Digital: A Cheap Stock With An Underappreciated Growth Opportunity (NASDAQ:GEN)

Lyntris: Defense Play Does Not Appear To Be A Defensive Investment (Pending:LYNX)

Singer Mari Wilson says famous beehive was not 'just what I always wanted' ahead of new album

Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much (AEHR)

Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)

KORU Medical Systems Stock Selloff Offers An Opportunity (NASDAQ:KRMD)

Eikon Therapeutics, Inc. (EIKN) Discusses Advances in PARP1 Biology and Next-Generation PARP Inhibitors in Oncology Transcript

Editors Picks

Docusign: The Market Hasn’t Caught Up To The Multiple Yet (NASDAQ:DOCU)

22 August 2026

DICK’S Sporting Goods Stock Is Hanging On By A Thread But Looks Like A Buy Ahead Of Q2

22 August 2026

Gen Digital: A Cheap Stock With An Underappreciated Growth Opportunity (NASDAQ:GEN)

22 August 2026

Lyntris: Defense Play Does Not Appear To Be A Defensive Investment (Pending:LYNX)

22 August 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Singer Mari Wilson says famous beehive was not 'just what I always wanted' ahead of new album

22 August 2026

Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much (AEHR)

22 August 2026

Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)

22 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.